SARS-COV-2: Learning the Lessons from our Experiences, A Critical and Personal Review

Abstract

The aims and objectives of this paper is to question established scientific thinking and medical protocols surrounding SARS-COV-2, stimulate debate, and consider alternative and more effective ways of screening and treating the severely affected patients which improve therapeutic outcomes and thereby reduce the complexity and cost of treating infected SARS-COV-2 patients. The paper argues that national quarantine or lockdown strategies among countries (as a preventive approach) exhibit many shortcomings and are based on a set of erroneous assumptions which enables the independently minded to consider alternative diagnostic and/or therapeutic strategies e.g. to quarantine only the ‘at-risk’ groups; which could be significant in the future. It raises for discussion a number of pertinent points e.g. (i) that the virus affects different patient groups in different ways; (ii) that the most severely affected who are at risk of death is currently the vast minority of the population, in particular those who are diabetic, obese and immunosuppressed; (iii) that chasing the virus using ‘test and trace’ methods should be augmented by advanced, remote screening methods to determine those in the most ‘at-risk’ groups who should be quarantined; and (iv) reviews the fundamental limitations of seeking only drug-based solutions instead of considering and focussing upon scientifically sustainable solutions based upon an understanding of the fundamental chemistry of biology.